Many studies on probiotics are aimed at restoring immune homeostasis in patients to prevent disease recurrence or reduce immune-mediated pathology. Of equal interest is the use of probiotics in sub-clinical situations, which are characterized by reduced immune function or low-grade inflammation, with an increased risk of infection or disease as a consequence. Most mechanistic studies focus on the use of probiotics in experimental disease models, which may not be informative for these sub-clinical conditions. To gain better understanding of the effects in the healthy situation, we investigated the immunomodulatory effects of two Lactobacillus probiotic strains, i.e. L. plantarum WCFS1 and L. salivarius UCC118, and a non-probiotic lactococcus strain, i.e. L. lactis MG1363, in healthy mice. We studied the effect of these bacteria on the systemic adaptive immune system after 5 days of administration. Only L. plantarum induced an increase in regulatory CD103
Introduction
The intestinal microbiota is largely mutualistic in nature and important for human health. Apart from its well-established role in nutrition, it is important in the development of the immune system and the maintenance of homeostasis of tolerance and immunity [1] . For instance, aberrant microbial colonization results in abnormal development of secondary lymphoid organs, reduced peripheral CD4
+ T cell frequencies, skewing towards a T helper-2 immune phenotype, absence of T and B cells in the gut-associated lymphoid tissue, and reduced immunoglobulin levels [2] [3] [4] . Further, an aberrant intestinal microbiota is not only associated with the risk of infection and the development of intestinal immune disorders, but also with immune disorders beyond the intestine, such as allergic skin-and respiratory disease [5] [6] [7] , and autoimmune diseases such as rheumatoid arthritis [8, 9] and diabetes type I [10] .
Administration of indigenous, non-pathogenic probiotic bacteria is a promising strategy to improve immune homeostasis and to maintain host health. Probiotics may improve host health by normalizing existing undesired immune responses, as is the case in allergy or autoimmune disease [11, 12] . These beneficial effects have been described in both diseased humans [13] [14] [15] , as well as in experimental disease models [16] [17] [18] [19] . Besides the beneficial effects in disease, probiotics may benefit persons who are not receiving medical treatment, but have an increased risk of infection or disease due to the deterioration or inflammatory status of their immune system. This applies not only for agerelated changes in immune function [20] , but also for individuals with a genetic predisposition [21] , obesity [22] , or malnutrition- [23] , stress-or lifestyle-induced declining immune function [24] . Although the beneficial effects of probiotics in non-diseased subjects have been described in experimental vaccination trails [25] [26] [27] and infection studies [25, [28] [29] [30] [31] [32] [33] [34] [35] , the immunomodulatory mechanisms behind these effects remain poorly understood.
Knowledge of how different probiotic strains can affect the immune system in the absence of disease, will gain mechanistic insights and help clarify the magnitude of their effects on the immune system, the strain dependency of these effects, their safety, and potential applications in maintaining or improving immune homeostasis. Surprisingly, the number of studies investigating the immunomodulatory effects of probiotics in non-diseased subjects is limited [36] [37] [38] . Most studies have focused on disease models [39] , with a strong perturbation of immune homeostasis and often skewing to a specific T helper cell response [39, 40] . Moreover, some disease models have a severely compromised intestinal barrier, which could alter the accessibility of the probiotics to the immune cells and the lymphoid tissues [41] . Therefore, studies in the disease state may not reflect and predict the immunomodulatory effects of probiotics in healthy individuals or persons with sub-optimal immune health. To address this gap in our understanding, we have investigated the immunomodulatory effects of probiotic bacteria in healthy, non-diseased mice.
The effects of orally administered L. plantarum WCFS1, L. salivarius UCC118, and L. lactis MG1363 on systemic T and dendritic cell populations and responses were investigated. Both L. plantarum WCFS1 and L. salivarius UCC118 are probiotic strains [42, 43] , whereas L. lactis MG1363 is not associated with probiotic effects [44, 45] . The bacteria were administered over 5 days, which is the period required for mice to develop an adaptive immune response [44, 45] . In this study, we demonstrated strain dependent effects of the bacteria on dendritic cells in vitro and in vivo and specific T cell responses in vivo and ex vivo.
Materials and Methods

Bacterial Strains and Growth Conditions
L. plantarum WCFS1 [46] and L. salivarius UCC118 [47] were cultured at 37uC in Man Rogosa and Sharpe (MRS) broth. L. lactis MG1363 [48] was cultured at 30uC in M17 broth containing 0.5% glucose. All bacterial cultures were grown overnight until the stationary phase of growth. Subsequently, the cultures were diluted 1:1000 in fresh medium and cultured for a second night to allow optimal growth. The optical density at 600 nm was measured and the number of colony forming units (CFU) was calculated based on standard growth curves. For all cultured bacterial strains, an OD 600 -value of 1 corresponds to 1-2610 9 CFU/mL, which was confirmed by plating serial dilutions on MRS or M17 agar plates (data not shown). To avoid bacterial manipulation and cell death, extensive washing and centrifuging was avoided. After overnight culture, a small portion of bacteria was diluted in fresh, sterile MRS broth and immediately administered to the animals. The mice received either sterile MRS broth or 1-2610 8 CFU bacteria in 200 mL MRS via intragastric gavage, daily.
In vitro Culture and Stimulation of Murine Dendritic Cells
Bone marrow cells were isolated and cultured as described by Lutz et al [49] , with minor modifications. Briefly, femora and tibiae from female 6 weeks old Balb/c mice (Charles River Breeding Laboratories, Protagem MI), were removed and stripped of muscles and tendons. After soaking the bones in 70% ethanol and rinsing in PBS, bones were carefully crushed with a mortar to release the bone marrow cells. Cells were filtered using Steriflip filtration and washed with RPMI medium. Bone marrow cells (2-4610  7 ) were seeded into Petri dishes in 10 ml RPMI 1640 Glutamax (Sigma-Aldrich, St. Louis, MO, USA) containing 10% (v/v) heat-inactivated fetal calf serum supplemented with penicillin (100 U/ml), streptomycin (100 mg/ml), 50 mm b-mercaptoethanol, and 20 ng/ml murine GM-CSF (R&D systems). The cells were incubated for 8 days at 37uC in 5% CO 2 humidified atmosphere. On day 3, 10 ml was removed and replaced with complete medium. On day 5, 5 ml fresh medium was added. On day 7, immature dendritic cells were collected and seeded in a 24 wells plate at 5610 5 cells/well. On day 8, the cells were either left unstimulated or stimulated with L. plantarum WCFS1, L. salivarius UCC118, L. lactis MG1363 (1:10 cell to bacteria ratio), or LPS (1 mg/mL). After 24 hours the concentration of IL10 and TNFa was determined in the culture supernatants using cytometric bead array (BD Biosciences). The cells were stained for the dendritic cell marker CD11c and the activation markers CD40 and CD86, or appropriate isotype controls (BD Biosciences).
Animals
Wild-type male Balb/c mice were purchased from Harlan (Harlan, Horst, The Netherlands). The animals were fed standard chow and water ad libitum. All animal experiments were performed after receiving approval of the institutional Animal Care Committee of the Groningen University. All animals received animal care in compliance with the Dutch law on Experimental Animal Care. The n-values were based on a mandatory power analysis. The values were 6 mice per experimental group, based on a type I error of 5% and a type II error of 10%.
To study the effect of lactobacilli on the systemic immune system, three bacterial strains (L. lactis MG1363, L. salivarius UCC118, and L. plantarum WCFS1), or MRS broth (carrier) only, were administered by intragastric gavage of a 200 mL volume once daily. The carrier and the bacterial strains were administered for five consecutive days. At day six, the mice were sacrificed, after which the spleen and mesenteric lymph nodes were removed for further analysis.
Cell Isolation and Restimulation
After sacrificing the mice, spleens and mesenteric lymph nodes (MLN) were removed for further analysis. Single cell suspensions were made by mechanical disruption of the tissue between two glass slides in 1 mL of ice-cold RPMI containing 10% (v/v) heat inactivated fetal calf serum (FCS). Subsequently, a cell strainer was used to remove remaining clumps. The cells were washed, counted, and used for staining.
Part of the cells of the spleen and MLN were stimulated, the rest was left unstimulated. 7610 6 cells from the spleen and MLN were restimulated in RPMI 10% FCS containing 40 nM Phorbol 12-myristate 13-acetate (PMA) (Sigma Aldrich) and 2 nM calcium ionophore (Ca 2+ ) (Sigma Aldrich). Monensin (3 mM) (Sigma Aldrich) was added to allow cytokine accumulation in the cellular cytoplasm. Cells were stimulated for four hours at 37uC, after which they washed twice in ice-cold PBS containing 2% heat inactivated FCS (FACS buffer), and used for staining.
DCs were enriched and dead cells were removed from the splenic and MLN cell suspensions. For this, 1 mL of cell suspension was loaded on 1 mL of 1-step Monocyte (Accurate Chemical and Scientific Corporation, Westbury, NY) with a density of 1.06860.001 g/ml, and centrifuged for 30 minutes at 3006g at 4uC. The interface was washed twice in ice-cold FACS buffer and used for staining. After density gradient centrifugation, more than 90% of the cells were vital, which was confirmed by propidium iodide staining.
Cell Staining
T cell stainings were performed on non-stimulated, nonenriched splenic and MLN cell suspensions. DC stainings were performed on non-stimulated, DC-enriched splenic and MLN cell suspensions. Stainings for intracellular cytokines were performed on PMA/Ca 2+ stimulated splenic and MLN cell suspensions. The T cell cocktail contained monoclonal antibodies directed against CD3, CD4, CD8, CD25, CD69, FoxP3, or appropriate isotype controls (Table I ). The DC cocktail contained monoclonal antibodies directed against CD11c, MHC II, CD19, CD80, CD86, CD103, or appropriate isotype controls (Table I) . The effector T cell cocktail contained monoclonal antibodies directed against CD3, CD4, CD8, IFNc, IL5, IL10, IL17, or appropriate isotype controls (Table 1) .
In short, 1610 6 cells were incubated in FACS buffer containing 10% normal mouse serum for 30 minutes to prevent non-specific antibody staining. Subsequently, the cells were incubated with a cocktail of primary antibodies for 30 minutes. The cells were fixed in FACS Lysing solution (BD Biosciences) for 30 minutes, in the dark. The tubes for intracellular cytokine staining were subsequently washed twice in 16 permeabilisation buffer (eBioscience) and incubated with the intracellular antibodies cocktails containing 2% normal rat serum in permeabilisation buffer for 30 minutes in the dark. The whole procedure was performed on ice.
Flow Cytometry
During flow cytometry, at least 5610 5 cells were analyzed. Flow Cytometry was performed using the LSR II Flow Cytometer system (BD Pharmingen), using FACS Diva software. Analysis was performed using FlowJo 7.6.2 software. Lymphocytes were gated based on the expression of CD3 and CD4 or CD8. The expression of CD25, CD69, FoxP3, and cytokines was determined based on samples stained with the isotype controls. Dendritic cells were gated in the forward side scatter plot, based on size, granularity, and the expression of MHC II + and CD11c
+
. CD19 + B-cells were excluded from analysis. The expression of CD80, CD86, and CD103 was determined based on samples stained with the isotype controls.
Statistics
All data are expressed as the mean 6 standard error of the mean (SEM). Normal distribution of the data-sets was confirmed by the Kolmogorov-Smirnov test. The one-way ANOVA, followed by a two-sided Dunnett post-hoc test was used to determine changes in immune cell populations after probiotic treatment in vivo. The two-sided Mann Whitney U-test was used to determine changes in cytokine release after probiotic co-incubation in vitro. P-values ,0.05 (*) were considered statistically significant.
Results
Strain Specific Release of Pro-and Anti-inflammatory Cytokines by Murine DCs
To confirm the immunomodulatory potential of our probiotic strains, we first performed an in vitro assay. For this, bonemarrow derived (BM) dendritic cell (DC) activation and cytokine responses were determined in response to L. plantarum WCFS1, L. salivarius UCC118, or L. lactis MG1363 (N = 4). Incubation of all bacteria with BMDCs led to cellular activation, as shown by an increased frequency of BMDCS expressing high levels of the activation markers CD86 and CD40 (gate) as compared to medium stimulated BMDCs ( Figure 1A ). In addition to BMDC activation, the release of pro-inflammatory TNFa and anti-inflammatory IL10 was measured. All three bacterial strains induced similar levels of TNFa ( Figure 1B) . Similarly, all bacteria induced IL10 ( Figure 1B ), but the IL10 response was highest for L. salivarius-treated BMDCs, albeit not statistically significant ( Figure 1B ).
Probiotic Treatment Increases the Frequency of Regulatory T Cells in a Strain Dependent Manner
Next, we evaluated the immunomodulatory properties of these strains in vivo. For this, we analyzed changes in the balance between different pro-inflammatory and regulatory T cell populations in the mesenteric lymph node (MLN) and spleen after consumption of the bacteria. In addition, dendritic cell (DC) frequencies and activation was determined, as DCs are important in both bacterial recognition as well as shaping local and systemic T cell responses [50] . The mice (N = 6 per group) received L. plantarum WCFS1, L. salivarius UCC118, L. lactis MG1363, or culture medium alone, for 5 consecutive days. First, we focused on the frequency of regulatory T cells following probiotic treatment.
Regulatory CD4
+ T cells were defined on the basis of FoxP3 expression ( Figure 2A ) and consistently showed high CD25 expression as compared to the total CD4 + T cell population (Figure 2A) . Systemic regulatory T cell frequencies were increased after probiotic treatment, in a strain-dependent manner. Only L. plantarum-treated mice demonstrated increased frequencies of regulatory T cells in the spleen as compared to medium treated mice ( Figure 2B ). This increase was not observed after treatment with L. salivarius or L. lactis ( Figure 2B ). In the MLN, a trend towards decreased regulatory T cell frequencies was observed after all bacterial treatments, but this never reached statistical significance [One-way ANOVA P = 0.07 ( Figure 2C) ]. 
CD4
+ T cell population. The gate was set based on staining with an isotype control. As a control, the expression of CD25 was determined within the total CD3 +
+ T cell population (blue line) and the regulatory T cell population (red line) and compared to an isotype control (grey line). Representative FACS plots are depicted (A). Regulatory T cell frequencies in the spleen (N = 6) (B) and mesenteric lymph node (N = 6) (MLN) (C) following oral treatment with medium (white bars), L. lactis MG1363 (dashed bars), L. plantarum WCFS1 (grey bars), or L. salivarius UCC118 (black bars). Results are depicted as the mean 6 standard error of the mean (SEM). Statistical significance was calculated using the One-way ANOVA followed by a two-sided Dunnet post-hoc test. * represents P-values ,0.05. doi:10.1371/journal.pone.0047244.g002 Figure 3E ). In the spleen, T cell activation was not affected by any of the treatments ( Figure 3B, 3D, 3F ). These results demonstrate that probiotic treatment can modify the balance between systemic pro-inflammatory and regulatory T cell populations in a strain dependent manner.
Probiotic Treatment Affects the Frequency of Polarized CD4 + T Cell Populations in a Strain Dependent Manner
In order to gain functional insight in the consequences of L. plantarum WCFS1, L. salivarius UCC118, and L. lactis MG1363 administration on T cell responses, we performed another series of experiments. Cells from the spleen and MLN were restimulated with PMA/Ca 2+ ex vivo, after which cellular cytokine responses were determined. IFN-c was measured as a marker for Th1 cells [51] . Th1 cells stimulate the cellular immune response, but are also involved in severe autoimmune processes [52] . IL5 is an accepted marker for the Th2 subset [51] , which stimulates humoral responses, but is also involved in allergy and asthma [52] . IL10 was measured as a marker for regulatory T cells [52] , which are involved in anti-inflammatory responses [52] . Finally, IL17 was measured as a marker for Th17 cells [46, 47] , which are involved in responses against fungi, but also in severe autoimmune responses [52, 53] . The frequency of cytokine producing CD4 + T cells was determined based on appropriate isotype controls ( Figure 4A ).
The bacterial treatments decreased Th2 responses, which was most pronounced in the MLN, but was also observed in the spleen. Further, the effects were dependent on the probiotic strain administered. All three bacterial strains decreased the frequency of Th2 cells in the MLN and spleen 2 to 3-fold as compared to medium-treated mice ( Figure 4D and 4E respectively) . In addition, a trend towards increased frequencies of IL10-producing CD4 + T cells was observed in the spleen following L. plantarum treatment ( Figure 4G ), although it didn't reach statistical significance. In addition to decreased Th2 frequencies, L. salivarius treatment also induced almost a 2-fold decrease in the frequency of Th17 cells in the MLN as compared to medium treatment ( Figure 4H ). Further, a trend towards a 2-fold decrease in Th1 frequencies was observed in the MLN following L. lactis treatment [P = 0.06) (Figure 4B) ].
Other polarized CD4
+ T cell frequencies were not affected by the treatments (Figure 4 ).
Probiotic Treatment Affects the Frequency of Cytokine Producing CD8 + T Cell Populations in a Strain Dependent Manner
Similar to the CD4 + T cell population, CD8 + effector T cells can be defined on the basis of pro-and anti-inflammatory cytokine responses after ex vivo restimulation [54] . The frequency of cytokine producing CD8 + T cells was determined based on appropriate isotype controls ( Figure 4B ). L. plantarum especially, increased the responsiveness of mesenteric and splenic CD8 + T cells, as judged by a 3-to 4-fold increase in frequencies of IFN-cproducing CD8
+ T cells in the MLN ( Figure 5B ) and spleen ( Figure 5C ). Further a 4-fold increase in IL17-producing CD8 + T cells was observed in the spleen after L. plantarum treatment ( Figure 5I 
Probiotic Treatment Affects the Distribution and Activation of (Intestinal) DCs
DCs are important in both bacterial recognition as well as shaping local and systemic T cell responses [50] . Therefore, we investigated the distribution of intestinal DCs and their activation status in the spleen and MLN. DCs were defined as CD11c + MHC II + cells ( Figure 6A ). Regulatory, intestinal DCs are depicted as the frequency of CD103 + cells within the DC population. Also the frequency of activated DCs was determined and depicted as the frequency of CD80 + or CD86 + cells within the DC population ( Figure 6A ).
Probiotic treatment only modestly affected intestinal DC trafficking to the MLN and spleen. Only L. plantarum-treated animals demonstrated a trend towards increased CD103 + DC frequencies in the spleen [P = 0.07 ( Figure 6B) ]. This influx of CD103 + DCs in the spleen was however not observed in the MLN ( Figure 6B ). Only L. salivarius-treated animals demonstrated a trend towards decreased DC activation in the spleen, as demonstrated by decreased frequencies of CD80 + DCs [P = 0.06 ( Figure 6D) ]. The activation status of splenic and mesenteric CD103 + DCs was not affected by any of the treatments (not demonstrated).
Discussion
In the present study we demonstrate that oral treatment with probiotic lactobacilli modifies the distribution of systemic (effector) T cell populations and DCs in both the MLN and the spleen. To our knowledge, this is the first report of systemic immune changes following short-term treatment with probiotic bacterial strains in healthy mice. We explored the basal immunomodulatory properties of probiotic strains in non-diseased animals and demonstrate that even a short-term period of probiotic consumption induces profound changes in cellular adaptive immune responses.
Although probiotics are generally marketed as a means to prevent disease in healthy individuals, most studies have focused on specific (intestinal) disease models [39] to demonstrate their efficacy. In such models, the immune homeostasis is often strongly perturbed and playing a role in the pathology [39, 40] . Additionally, the intestinal barrier may be compromised, altering the contact between the immune cells and the probiotic bacteria [41] . Therefore, studies in the disease state may not reflect and predict the immunomodulatory effects of probiotics in other diseases, or healthy individuals. Knowledge of how different probiotic strains can affect the immune system in the absence of disease, will gain mechanistic insights and help clarify the magnitude of their effects on the immune system, the strain dependency of these effects, their safety, and potential applications in maintaining or improving immune homeostasis. This will ultimately open up possibilities to select specific probiotics for specific immunological diseases, and as a means to prevent the development of disease [19, 55] or infection [25, 30, 31, 33] in healthy or subclinical individuals. For these reasons, we chose to study the systemic immunomodulatory properties of probiotic bacteria in healthy, non-diseased mice.
During recent years, much attention has been focused on the direct anti-inflammatory capacities of lactobacilli on tolerogenic dendritic cells (DCs) [17] , the generation of regulatory T cells in vivo and in vitro, or the induction of IL10 in in vitro assays [17, 45, [56] [57] [58] [59] . However, there are also reports that demonstrate Lactobacillus-induced suppression of pro-inflammatory immune responses, independent of IL10 or regulatory T cells [58, [60] [61] [62] . To date, it remains largely unknown in what manner lactobacilli affect the balance between of pro-and anti-inflammatory immune cell populations in vivo. Our data suggest that, depending on the bacterial strain administered, both processes, i.e. regulatory DC and T cell dependent and independent immunomodulation, can occur in healthy mice.
Our study clearly demonstrates that probiotic-induced immunomodulation is strain-dependent. Further, we demonstrate that strain-dependent immunomodulation is also a systemic phenomenon. L. plantarum WCFS1 consumption directly increased the frequency of regulatory T cells, while decreasing the responsiveness of Th2 cells and increasing the responsiveness of CD8 + T cells. Treatment with L. salivarius UCC118 did not affect the frequency of regulatory T cells; however, it decreased the responsiveness of Th2 cells. Further, L. salivarius treatment only modestly increased the CD8 + T cell responsiveness. These results have important implications for the expected health benefits exerted by the different probiotic strains.
Our results suggests that the immunomodulatory effects induced by L. plantarum may prove useful in the prevention or treatment of common Th2-skewed allergic diseases, such as atopic dermatitis, food allergy, and allergic asthma, and also as an adjuvant to boost the immune response to common viral infections that require the activation of CD8 + T cells, as for instance influenza. However, the drawback of this strain may be that it has effects on more than one immune cell subset. It may positively affect Th2-skewed allergic diseases, while at the same time it may increase the susceptibility for Th1-skewed diseases. This drawback is not seen for L. salivarius, which showed a clear reduction of Th2 responsiveness combined with only a modest increase in CD8
+ T cell responsiveness. The modest effect on CD8 + T cell responsiveness suggests that this probiotic may be less effective in boosting responses that specifically require CD8 + T cell participation. Taken together, our data demonstrate that these differential probiotic immunomodulatory properties may be used to develop tailored health promoting probiotic-based strategies.
Treatment with L. plantarum WCFS1 was associated with profound skewing towards an immune regulatory phenotype within systemic T helper cells. These results are in line with studies that demonstrate L. plantarum-induced immune regulation in vitro [63, 64] as well as in the duodenum [38, 65] . The observed changes were accompanied by the infiltration of intestinal CD103 + DCs in the spleen. Since it has been demonstrated that intestinal DCs are indispensable for probiotic-induced immunomodulation in vivo [66] and that these cells are highly important in generating regulatory responses [67] , our data suggest that systemic immune regulation is induced through L. plantarum-stimulated migration of regulatory CD103
+ intestinal DCs to immunological induction sites as far as the spleen. With this study, we demonstrate that L. plantarum WCFS1 not only attenuates local intestinal immune responses at the site of interaction [65] , but also profoundly affects the systemic immune system by skewing it to a more regulatory T helper phenotype.
L. plantarum WCFS1 not only skewed T helper cells towards an immune regulatory phenotype, but simultaneously increased the responsiveness of CD8 + T cells. This dual effect was never demonstrated for this strain before and appears to be in conflict with the observed Th hyporesponsiveness. Our observation may, however, be explained by the increased Th1/Th2 ratio caused by the reduction in Th2 frequencies. This demonstrates that L. plantarum not only stimulates skewing towards immune regulation, but can also directly improve the responsiveness of CD8 + T cells by leaving the Th1 subset unaltered. Our results corroborate previous in vitro findings [68, 69] . Also, several reports have indirectly demonstrated improved CD8 + T cell responsiveness following probiotic treatment, by demonstrating improved immune responses towards viral infections in vivo [28] [29] [30] [31] [32] .
During recent years, many in vitro screening tools have been developed to predict the beneficial effect of probiotic bacteria in vivo [45, 62, 70, 71] . The majority of these systems focus on the secretion of only one or a few pro-and anti-inflammatory cytokines from PBMCs or DCs as a model for immunomodulation in vivo. In this study, we demonstrate that using this strategy potential efficacious probiotic strains may be missed. For instance L. plantarum has been demonstrated as a modest cytokine inducer in vitro [62, 70, 71] , which is also apparent from the results of our in vitro murine dendritic cell assay. However, this strain possesses + dendritic cell subsets in profound immunomodulatory properties in vivo. Further, the results from our in vitro assay, as well as previously published reports [57, 72] suggest that L. salivarius is a potent immunomodulator in vivo. Although L. salivarius had some systemic immunomodulatory effects, these were only modest and not as pronounced as the effects observed after L. plantarum treatment. These modest immunomodulatory effects in vivo may also explain the variable performance of this strain in disease models [73] [74] [75] . These in vivo disease models highly depend on Th1 reactivity [76] , which, according to our data, is only marginally affected by L. salivarius. We therefore feel that the use of in vitro screening models may be valuable as a high through-put screening tool for potential probiotic strains, but the immunomodulatory properties of the bacterial strains should always be confirmed in vivo, or in more complex in vitro models. L. lactis is not considered to be a strain with probiotic capacities [44, 45] . We did, however, observe immunomodulation following L. lactis treatment, both in our in vitro assay, as well as in vivo. Previous studies have demonstrated the importance of bacterial wall proteins for the interaction with immune cells and probiotic effects [64] . It may well be that also L. lactis has specific bacterial wall components that are recognized by dendritic cells in the intestine and influence DC function [77] . Much more research efforts should be employed to understand the exact interactions between bacterial wall components, specific immune cell receptors, and the consequences for the immune system, to fully understand and predict the probiotic and non-probiotic immunemodulatory effects of bacteria in vitro and in vivo. This unexpected immunomodulating potency of L. lactis suggests that caution should be taken in categorizing bacteria in probiotic versus nonprobiotic.
Our study was not only undertaken to unravel the immediate effects of short-term administration of probiotics on cellular adaptive immune responses, but also to investigate if systemic biomarkers could be identified that would reflect the efficacy of probiotics in vivo. In humans, we can only access the systemic circulation to study immunomodulation and the efficacy of probiotics. As demonstrated in this study, the efficacy can effectively be assessed by measuring pro-and anti-inflammatory cytokine responses after restimulation of T cells ex vivo. We found clear differences, which were pronounced enough to distinguish strain dependent effects. Clear documentation of these parameters may help to understand the large differences in reported effects of different probiotic strains.
In summary, in the current study we demonstrated systemic immunomodulation following short-term oral administration of three bacterial strains in healthy mice. Although further research is necessary to investigate the implications of these immune changes for a beneficial effect in human health, our results suggest that the selection of specific probiotic strains for enforcing specific desired immune responses may be a promising strategy to improve host health. the spleen (N = 6) (B) or mesenteric lymph node (N = 6) (C) following oral treatment with medium (white bars), L. lactis MG1363 (dashed bars), L. plantarum WCFS1 (grey bars), or L. salivarius UCC118 (black bars 
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